These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


130 related items for PubMed ID: 9066501

  • 1. Ratio of inhaled corticosteroid to bronchodilator as indicator of quality of asthma prescribing. More adequate information systems are needed.
    Currie CJ, Evans M, Morgan CL.
    BMJ; 1997 Mar 01; 314(7081):681; author reply 682. PubMed ID: 9066501
    [No Abstract] [Full Text] [Related]

  • 2. Ratio of inhaled corticosteroid to bronchodilator as indicator of quality of asthma prescribing. Prescribing data need to be available by age.
    Baumer JH.
    BMJ; 1997 Mar 01; 314(7081):681; author reply 682. PubMed ID: 9066500
    [No Abstract] [Full Text] [Related]

  • 3. Ratio of inhaled corticosteroid to bronchodilator as indicator of quality of asthma prescribing. Authors discuss a result that was not shown.
    Roberts SJ.
    BMJ; 1997 Mar 01; 314(7081):680-1; author reply 682. PubMed ID: 9066499
    [No Abstract] [Full Text] [Related]

  • 4. Should the corticosteroid to bronchodilator ratio be promoted as a quality prescribing marker?
    Frischer M, Heatlie H, Chapman S, Norwood J, Bashford J, Millson D.
    Public Health; 1999 Sep 01; 113(5):247-50. PubMed ID: 10557120
    [Abstract] [Full Text] [Related]

  • 5. Ratio of inhaled corticosteroid to bronchodilator as indicator of quality of asthma prescribing. Outcome measures need to reflect morbidity and quality of care.
    Griffiths C, Sturdy P, Naish J, Feder G, Omar R, Dolan S, Pereira F.
    BMJ; 1997 Mar 01; 314(7081):681-2. PubMed ID: 9066502
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of indicators assessing the quality of drug prescribing for asthma.
    Veninga CC, Denig P, Pont LG, Haaijer-Ruskamp FM.
    Health Serv Res; 2001 Apr 01; 36(1 Pt 1):143-61. PubMed ID: 11324741
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhaled corticosteroids in asthma action plans--double or quits?
    Crane J.
    N Z Med J; 2004 Jun 18; 117(1196):U930. PubMed ID: 15280934
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Long-acting beta 2-agonists in addition to inhaled corticosteroids in children and adults with chronic asthma. A survey of two Cochrane reviews].
    Ulrik CS.
    Ugeskr Laeger; 2007 Mar 12; 169(11):997-1001. PubMed ID: 17371632
    [No Abstract] [Full Text] [Related]

  • 14. [No risk of development of osteoporosis or inhibition of growth in children with asthma treated with inhaled corticosteroids].
    Pedersen SE, Bisgaard H, Schiøtz PO.
    Ugeskr Laeger; 2005 Jun 06; 167(23):2502-3. PubMed ID: 16008003
    [No Abstract] [Full Text] [Related]

  • 15. Changes in inhaler devices for asthma and COPD.
    Capriotti T.
    Medsurg Nurs; 2005 Jun 06; 14(3):185-94. PubMed ID: 16035636
    [No Abstract] [Full Text] [Related]

  • 16. Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial.
    Rowe BH, Wong E, Blitz S, Diner B, Mackey D, Ross S, Senthilselvan A.
    Acad Emerg Med; 2007 Oct 06; 14(10):833-40. PubMed ID: 17898245
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.